Statistical Basis for Hemochromatosis Screening
NCT00005559 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-02-18
Summary
To determine optimal values for transferrin saturation for use in population screening for hereditary hemochromatosis.
Conditions
- Blood Disease
- Hemochromatosis
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Christine Mc Laren · Moorhead State University
Eligibility
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-07-31
- Completion
- 2000-06-30
More Related Trials
-
HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
NCT01784939 ·Status: COMPLETED
-
Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis
NCT01810965 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
NCT00000595 ·Status: COMPLETED ·Phase: PHASE2
-
The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
NCT05214105 ·Status: RECRUITING
-
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
NCT01398644 ·Status: UNKNOWN ·Phase: PHASE3
-
T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients
NCT00520559 ·Status: COMPLETED
-
Measurements of Body Iron Excretion of Healthy Adults
NCT00755105 ·Status: COMPLETED
-
Hemoglobin and Iron Recovery Study
NCT01555060 ·Status: COMPLETED ·Phase: PHASE2
-
Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
NCT01556360 ·Status: COMPLETED
-
Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada
NCT05506358 ·Status: COMPLETED ·Phase: NA
-
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
NCT00440986 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Utility of Fibroscan in Estimating Hepatic Iron Concentration
NCT02067130 ·Status: UNKNOWN ·Phase: NA
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
Iron Replacement in Blood Donors
NCT00327067 ·Status: COMPLETED
-
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
NCT00202436 ·Status: COMPLETED ·Phase: PHASE3
-
Candidate Gene for Hyperferritinemia
NCT05659017 ·Status: RECRUITING
-
Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis
NCT04779593 ·Status: RECRUITING ·Phase: NA
-
Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations
NCT01911871 ·Status: COMPLETED
-
Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity
NCT02619955 ·Status: COMPLETED
-
Frequency and Impact of Iron Deficiency in Pain Clinic Patients
NCT06665516 ·Status: COMPLETED
-
PTG-300 in Subjects With Hereditary Hemochromatosis
NCT04202965 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-Center Study of Iron Overload: Pilot Study
NCT01114776 ·Status: COMPLETED
-
Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement
NCT03990181 ·Status: COMPLETED ·Phase: NA
-
Deferoxamine for the Treatment of Hemochromatosis
NCT00001203 ·Status: COMPLETED
-
Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)
NCT03203850 ·Status: TERMINATED ·Phase: PHASE2